PMID: 8952726Jan 1, 1996Paper

Evaluation of the reagent "IL Test LAC Screen/IL Test LAC Confirm" for the biological diagnosis of circulating lupus anticoagulants

Annales de biologie clinique
A Magdelaine, E Verdy

Abstract

Lupus anticoagulants (LA) are immunoglobulins which interfere with in vitro phospholipid-dependent coagulation tests. Its presence is associated with thromboembolic events. Laboratory recognition of these inhibitors is therefore of increasing clinical importance. A variety of tests has been introduced to detect LAs. In this study, 'IL Test LAC Screen/LAC Confirm', a new sensitive LA test, is evaluated on 23 LA-positive and 70 LA-negative plasmas. In this procedure, a dilute Russell's viper venom is served as a screening test with addition of phospholipids as a confirmatory test. A correct sensitivity for LAs is observed. This new approach for biological LA diagnosis may contribute to an accurate LA recognition in association with one or more phospholipid-dependent coagulation tests.

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.